In last trading session, Applied Dna Sciences Inc (NASDAQ:APDN) saw 0.33 million shares changing hands with its beta currently measuring 0.44. Company’s recent per share price level of $0.85 trading at -$0.01 or -1.73% at ring of the bell on the day assigns it a market valuation of $5.50M. That closing price of APDN’s stock is at a discount of -29723.53% from its 52-week high price of $253.50 and is indicating a premium of 15.29% from its 52-week low price of $0.72. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.97 million shares which gives us an average trading volume of 1.22 million if we extend that period to 3-months.
For Applied Dna Sciences Inc (APDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -3.0 in the current quarter.
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Upright in the red during last session for losing -1.73%, in the last five days APDN remained trading in the green while hitting it’s week-highest on Tuesday, 04/22/25 when the stock touched $0.85 price level, adding 10.42% to its value on the day. Applied Dna Sciences Inc’s shares saw a change of -91.70% in year-to-date performance and have moved 4.45% in past 5-day. Applied Dna Sciences Inc (NASDAQ:APDN) showed a performance of -58.88% in past 30-days. Number of shares sold short was 0.74 million shares which calculate 0.34 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 1.5 to the stock, which implies a rise of 43.33% to its current value. Analysts have been projecting 1.5 as a low price target for the stock while placing it at a high target of 1.5. It follows that stock’s current price would drop -76.47% in reaching the projected high whereas dropping to the targeted low would mean a loss of -76.47% for stock’s current value.
Applied Dna Sciences Inc (APDN) estimates and forecasts
This year revenue growth is estimated to rise 53.99% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.19M for the same. And 1 analysts are in estimates of company making revenue of 1.28M in the next quarter. Company posted 929.63k and 797.52k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 60.68% during past 5 years.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Insiders are in possession of 3.31% of company’s total shares while institution are holding 4.76 percent of that, with stock having share float percentage of 4.92%. Investors also watch the number of corporate investors in a company very closely, which is 4.76% institutions for Applied Dna Sciences Inc that are currently holding shares of the company. MATHER GROUP, LLC. is the top institutional holder at APDN for having 700.0 shares of worth $287.0. And as of 2024-06-30, it was holding 0.0803 of the company’s outstanding shares.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 5.62 shares of worth $4758.0 or 0.09% of the total outstanding shares. The later fund manager was in possession of 1.06 shares on Feb 28, 2025 , making its stake of worth around $897.0 in the company or a holder of 0.02% of company’s stock.
